Business Wire

OPEX ® Corporation Partners with DATAWIN GmbH to Distribute InoTec Document Scanners Worldwide

24.9.2025 10:00:00 CEST | Business Wire | Press Release

Share

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for document and mail automation, has entered into a partnership agreement with DATAWIN GmbH, a leading manufacturer of premium document scanners, enabling OPEX to offer DATAWIN’s InoTec document scanners at the global level.

For DATAWIN, based in Ergolding near Landshut, Germany, this alliance opens new international markets, as it represents the company’s first global distribution partnership. DATAWIN’s existing country- and region-specific distribution agreements will remain in place. For OPEX, the collaboration further expands its portfolio with the addition of desktop document scanners to its current scope of offerings.

“We are delighted to partner with OPEX,” said Johannes Boerboom, CEO and Partner, DATAWIN GmbH. “Through its global distribution network, OPEX opens access to markets that were previously beyond our reach. At the same time, OPEX’s tightly woven, in-house service network ensures world-class support for InoTec installations worldwide. This makes the partnership with OPEX a cornerstone of our internationalization strategy. We firmly believe we build the world’s best desktop document scanners―and we want them to be deployed globally. OPEX’s automation solutions provide an excellent environment for exactly that.”

OPEX Corporation’s state-of-the-art document and mail automation solutions serve a wide range of industries, including service bureaus, banking and finance, insurance, law, government, nonprofit, and more. The company’s document imaging and scanning portfolio includes its flagship Gemini® and Falcon+® series, featuring revolutionary One Touch document scanning, flexible imaging, and unmatched efficiency.

"At OPEX, our mission has always been to engineer unique automated solutions that help our clients solve even the most complex business challenges,” said David Stevens, President and CEO, OPEX. “In partnering with DATAWIN, we’ve found a company that shares our core values. Like OPEX, DATAWIN is privately held, deeply committed to long-term customer relationships, and designs and builds its own scanners to ensure the highest levels of quality and reliability. By offering InoTec desktop scanners alongside our proven Gemini and Falcon scanners, we can deliver the most flexible and reliable portfolio of scanning solutions on the market.”

About OPEX

OPEX® Corporation is a global leader in Next Generation Automation, providing innovative, unique solutions for warehouse, document and mail automation. With headquarters in Moorestown, NJ—and facilities in Pennsauken, NJ; Plano, TX; France; Germany; Switzerland; the United Kingdom; and Australia—OPEX has nearly 1,600 employees who are continuously reimagining and delivering customized, scalable technology solutions that solve the business challenges of today and in the future. The year 2025 marks the company’s 50th anniversary under the multigenerational ownership and leadership of the Stevens family.

About DATAWIN

DATAWIN GmbH, headquartered in Ergolding near Landshut, Germany, brings together three independent scanner and imaging brands: DATAWIN, InoTec SCAMAX®, and BAPIS. The DATAWIN brand develops, designs, and manufactures custom high-volume OMR scanners and related components. The InoTec SCAMAX® brand, based in Wölfersheim, Hesse, optimizes capture processes for clients worldwide with its highly reliable InoTec SCAMAX® document scanners and sorters—empowering them to achieve outstanding Intelligent Document Processing (IDP). The BAPIS brand offers industry and research clients application-optimized solutions and consulting in imaging and digital control. This includes the development, design, production, and refinement of hardware, software, and firmware. DATAWIN GmbH’s products are used across industries and around the world—wherever large volumes of paper-based information need to be digitized, processed, and sorted quickly and reliably. Typical applications include document archiving, inbound mail and receipt capture, elections, and documentation workflows. DATAWIN GmbH is certified under the European ISO 9001:2015 quality standard and is part of the extended corporate group of DATAGROUP, one of Germany’s leading IT service providers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250924616392/en/

Contacts

For OPEX Corporation
Laura Evans
levans@opex.com
+1.856.727.1100 x 5012

For DATAWIN GmbH
Martin Schrittenlocher
martin.schrittenlocher-ext@datawin.de
+49 172 8502464

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye